Biotech stocks have been hammered over the last year, with many currently trading at or below book value. A reversal is due.
Some indications of a reversal in the short term with possible test of 118-120:
1. Price broke last low but is currently forming a bullish hammer. 2. Bullish divergence on the MACD histogram. 3. ADX below 20 indicates sell off is weak.